Danita H. Schuurhuis

Author

Also Known As

D H Schuurhuis, D Schuurhuis, D. Schuurhuis, D.H. Schuurhuis, Danita H Schuurhuis, Danita H. Schuurhuis, Danita H. Schuurhuis (318329), Danita Schuurhuis

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Leiden University Medical Center Radboud University Nijmegen Radboud University Medical Center Genmab (Netherlands)Institute of Haematology and Blood Transfusion

About

Danita H. Schuurhuis is an author at Leiden University Medical Center specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.4K
2	Immunology	10	10	1.3K
3	Cell Biology	8	8	1.1K
4	Allergy	3	3	461
5	Cellular Physiology	1	1	282

Danita H. Schuurhuis

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells Monique J. Kleijmeer, Georg Ramm, Danita H. Schuurhuis, The Journal of Cell Biology ImmunologyMolecular BiologyAntigen ProcessingExtracellular MicrovesiclesCytoskeleton	2001	282
Antigen-Antibody Immune Complexes Empower Dendritic Cells to Efficiently Prime Specific CD8+ CTL Responses In Vivo Danita H. Schuurhuis, Andreea Ioan‐Facsinay, Bas Nagelkerken, The Journal of Immunology	2002	229
An Antibody–Drug Conjugate That Targets Tissue Factor Exhibits Potent Therapeutic Activity against a Broad Range of Solid Tumors Esther C.W. Breij, Bart E.C.G. de Goeij, Sandra Verploegen, Cancer Research Tf HumabSolid TumorsImmunologyImmunotherapyAntibody–drug Conjugate That	2013	214
Expression of the Serpin Serine Protease Inhibitor 6 Protects Dendritic Cells from Cytotoxic T Lymphocyte–Induced Apoptosis Jan Paul Medema, Danita H. Schuurhuis, Delphine Réa, The Journal of Experimental Medicine ApoptosisImmunologyProtects Dendritic CellsCell DeathImmunologic Mechanism	2001	205
Expression of the Murine CD27 Ligand CD70 In Vitro and In Vivo Kiki Tesselaar, Yanling Xiao, Ramon Arens, The Journal of Immunology	2003	198
Immature Dendritic Cells Acquire Cd8+Cytotoxic T Lymphocyte Priming Capacity upon Activation by T Helper Cell–Independent or–Dependent Stimuli Danita H. Schuurhuis, Sandra Laban, René E. M. Toes, The Journal of Experimental Medicine	2000	194
DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing Patrick Engelberts, Ida H. Hiemstra, Bart de Jong, EBioMedicine	2020	159
Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell–Based Vaccination Erik H.J.G. Aarntzen, I. Jolanda M. de Vries, W. Joost Lesterhuis, Cancer Research Adaptive Immune SystemImmunodeficienciesImmunologyImmunoeditingImmunodominance	2012	153
Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration A.C.I. Boullart, Erik H.J.G. Aarntzen, Pauline Verdijk, Cancer Immunology Immunotherapy	2008	150
Immunization with human papillomavirus type 16 (HPV16) oncoprotein-loaded dendritic cells as well as protein in adjuvant induces MHC class I-restricted protection to HPV16-induced tumor cells. M L De Bruijn, Danita H. Schuurhuis, Michel Vierboom, PubMed ImmunologyImmunotherapyCancer-associated VirusTumor ImmunologyHuman Papillomavirus Vaccines	1998	141

Page 1